Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

I understand completely Numbers. As a former sales

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154898
(Total Views: 622)
Posted On: 08/05/2020 12:46:53 PM
Posted By: expharmer
Re: nmbr1stckpckr #47248
I understand completely Numbers. As a former sales rep I can tell you how this is happening. XX drug rep walks into hospital/ clinic. hey doc great to see you...not much new with XX drug how did it work with your last RA patient? Great, remember safety profile, no syncope in elderly patients. Doc,"Yep got it! hey just saw you all on the news about the phase 2/3 COVID trial, any news yet on FDA approval? How's it looking? Rep, " the press release looked good, they released some safety data- you can check it out on the website can't really talk about yet, I'll keep you posted on approval. BTW we are enrolling patients for the severe trial, trying to enroll xxx# asap, here's contact info if you need it just call this number and the company will do the rest!" Doc, "remind me of the MOA again and let me have a few more of those for my friend that works in ER/ICU we have had a huge upsurge in critical patients" Rep, No problem see you next week!"

I get we have to tread carefully with FDA and I think NP is so right with that belief! But I do think that there is a lot of competition out there and physicians will chose products based on prior experience with drug or company AND to many doctors a Mab is a Mab. Differentiators like "Immune modulator", exact and NOVEL 3 prt MOA, 4 years of safety data.

Just take a look at media, FDA, NIH can't wrap their heads around any difference in MOA of the Mabs being touted- everyone is lumped together. This thinking WILL benefit Big Pharma- they are happy to be misunderstood especially if it means being on the winning team- there motto has always been Dr. keep me in your top 3 therapies for RA and now COVID.

At the end of the day, I am hopeful that our leadership anticipates and plans a real campaign for Leronlimab and doesn't simply EXPECT overnight success with out any effort or expense. That might have worked with approval 3 months ago- competitor landscape has changed, we need to evolve as well. I am all in, very Long and ready to start developing key opinion leaders on go!






(5)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us